TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Themis Medicare Limited ( (IN:THEMISMED) ) has provided an update.
Themis Medicare Limited announced the appointment of Ms. Neha Thakore as an Independent Director and Mr. Viraj Save as Executive President of Sales & Marketing, effective August 1, 2025. These appointments are part of the company’s strategic efforts to strengthen its leadership team and enhance its market position. Additionally, the company approved its unaudited financial results for the quarter ending June 30, 2025, and set a record date for determining dividend entitlements, indicating a focus on financial transparency and shareholder value.
More about Themis Medicare Limited
Themis Medicare Limited operates in the pharmaceutical industry, specializing in Active Pharmaceutical Ingredients (API) and other pharmaceutical products. The company focuses on strategic growth and sustainability, with a strong emphasis on corporate governance and industry development.
Average Trading Volume: 16,949
Technical Sentiment Signal: Sell
Current Market Cap: 9.89B INR
Learn more about THEMISMED stock on TipRanks’ Stock Analysis page.